Business Wire

THE-UNNAMED-SOCIETY

25.10.2021 10:32:07 CEST | Business Wire | Press release

Share
The Unnamed Society Kicks Off Chapter II of The Book on The Art of Gifting at the 2021 SIAR International Watch Salon in Mexico City

Following through on its unique reinterpretation of Pancho Villa’s Bisley Colt introduced in 2019, The Unnamed Society takes the natural next step with Golden Boy , a reimagination of the legendary Winchester repeating rifle.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211025005046/en/

Golden Boy is a work of art in form and function that adds a new dimension to a story that remains as fascinating and inspiring as ever, that of the Wild West and how it was won.

A true-to-the-legend reimagination of the iconic lever action rifle as a clock, its original loading and cocking mechanism rethought for winding the timekeeping calibre and setting the time. Holding – and beholding – this uniquely fascinating feat of engineering and artisanship evokes childhood dreams of a far-away age that ultimately helped shape our modern times. It can be displayed to great effect both on a desk, mantelpiece or on the wall.

Golden Boy doesn’t just tell time, but opens our imagination and takes us to where the buffalo once roamed and brave men and women struck out into the unknown, stood their ground and built a new world.

Today, the partnership between The Unnamed Society and the watch company l’Epée 1839 opens the second chapter of its unfolding history. With Golden Boy comes the second stunning creation imagined for those who set the bar for the Art of Gifting a bit higher than the rest.

Nicknamed the ‘Gun that Won the West,’ the Winchester Rifle remains one of the most iconic firearms of all time. For the gun that inspired Golden Boy , the year is 1866. It has the same dimensions and weight as the original, the same feel and heft.

Able to hold 15 rounds before having to reload, the original was not only much more practical than a single-shot rifle, but also allowed for excellent handling and accuracy without any significant training.

The watchmaker captures this defining movement of the hand as it loads the round and prepares the gun for firing: by having the clock mechanism wound – ‘loaded’ – in exactly the same way. By actioning the lever 15 times – as if loading 15 bullets one after the other – the mechanism is fully wound for a 7-day power reserve.

If marvel at the heart of each Golden Boy is only matched by the fact that it only comes as a bespoke creation, completely finished to the owner’s wishes. For the receiver, barrel and tubular magazine, the owner can choose from steel, 18K yellow, rose or white gold, and palladium. For the stock and forestock, from a selection of exotic woods.

Press Material: TUSSIAR2021 - Google Drive

Link:

ClickThru

Social Media:

https://www.facebook.com/theunnamedsociety

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

PNCC Selects LotusFlare to Power Digital BSS and Commerce Platform for New 4G/5G Standalone Network26.2.2026 13:04:00 CET | Press release

LotusFlare, a provider of a cloud-native, AI-driven digital commerce and monetization platform for communications service providers (CSPs), today announced that Palau National Communications Corporation (PNCC) has selected it to provide a comprehensive commerce and monetization platform, including a full-stack digital business support system (dBSS) as part of PNCC’s broader 4G/5G Standalone (SA) network modernization programme. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260226869218/en/ Palau National Communications Corporation (PNCC) The LotusFlare solution will support PNCC subscribers across mobile, fixed broadband, and digital TV services, while enabling unique multi-tenant capabilities aligned with PNCC’s long-term digital and regional strategy. PNCC has embarked on a comprehensive technology modernization program focused on increasing speed-to-market, enhancing customer experience, and long-term operational efficie

GoldState Music and Bridgepoint Announce Strategic Partnership Targeting Growth Investments26.2.2026 13:00:00 CET | Press release

Capital will support GoldState Music’s Growth Strategy which will invest in scalable, profitable music-oriented businesses across the music value chainBridgepoint commits a significant investment as lead investor in GoldState’s Growth Strategy Bridgepoint, one of the world’s leading mid-market investors, today announced that it has entered into a strategic partnership with GoldState Music, a premier music investment platform, committing a significant investment as lead investor in GoldState’s Growth Strategy. The capital will support a dedicated investment programme focused on building and scaling high-quality music-oriented businesses globally. GoldState Music is a private investment firm founded in 2022 by industry veteran Charles Goldstuck, who played an integral role in the development of many music enterprises as well as in the careers of numerous major artists and songwriters. The company’s Growth Strategy is focused on investing in and scaling growing businesses operating in the

Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics26.2.2026 13:00:00 CET | Press release

Transformative clinical pipeline transaction will add CL-273, a pan-EGFR inhibitor, and CL-741, a Phase 1-Ready c-MET inhibitor, to Kairos Pharma's clinical portfolio to target multi-billion dollar lung cancer market. Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces the signing of a term sheet for a strategic asset acquisition with Celyn Therapeutics, Inc., a privately held biotechnology company backed by OrbiMed and Torrey Pines Investment. Under the proposed terms of the agreement, Kairos Pharma will acquire worldwide rights to two highly differentiated, clinical-stage oncology assets targeting non-small cell lung cancer (NSCLC): CL-273, a pre-IND, reversible, wild-type-sparing pan-EGFR inhibitor, and CL-741, a Phase 1-ready, orally available type IIb c-MET kinase inhibitor. John Yu, M.D., Kairos Pharma Chief Executive Officer, commented: "We anticipate this acquisition will significantly

Amazfit Introduces the Active 3 Premium: Turning Daily Movement into Meaningful Progress for Entry-Level Runners26.2.2026 13:00:00 CET | Press release

Premium materials, a 12-day battery life and new running features provide support for those kicking off their running journey Amazfit, a leading global smart wearable brand owned by Zepp Health, today announced the Amazfit Active 3 Premium, a compact, 4-button smartwatch designed as an entry point into structured running and hybrid training. Made for athletes building consistency across different forms of training, the Active 3 Premium supports road running and hybrid routines that combine endurance, strength, and studio-based workouts. Its compact design makes it easy to train across environments, from neighborhood runs to studio floors, offering a capable, approachable experience without feeling overbuilt or intimidating. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260226378156/en/ Made for athletes building consistency across different forms of training, the Active 3 Premium supports road running and hybrid routines th

Wyss Geneva Spin-Off Clee Medical Secures Seed Financing to Bring Real-Time Vision to Brain Surgery26.2.2026 12:49:00 CET | Press release

The Wyss Center for Bio and Neuroengineering Geneva announced today the successful closing of the Seed financing round of Clee Medical SA, a Swiss neurotechnology spin-off developing ultra-high-resolution real-time intraoperative imaging for brain surgery. The round was led by High-Tech Gründerfonds (HTGF), with participation from Zürcher Kantonalbank (ZKB), Kickfund, FONGIT, and Venture Kick joining existing investors Wyss Center Geneva. Clee Medical spun-out from Wyss Geneva’s Minimally Invasive Intracranial Access (MICA) research project in December 2024. Its flagship platform, Neuro Access, combines OCT imaging with advanced navigation to help neurosurgeons visualize brain anatomy and critical structures in real time during stereotactic procedures. “Clee Medical not only holds the promise of improving patient outcomes but also highlights Wyss Geneva’s dedication to bridging the gap between scientific discovery and real-world impact.” Dr. Erwin Böttinger, CEO, Wyss Geneva “Neurosurg

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye